vs
EQUITY BANCSHARES INC（EQBK）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
PUMA BIOTECHNOLOGY, INC.的季度营收约是EQUITY BANCSHARES INC的1.2倍（$75.5M vs $63.5M），EQUITY BANCSHARES INC同比增速更快（28.4% vs 27.7%），EQUITY BANCSHARES INC自由现金流更多（$38.1M vs $14.4M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 6.6%）
繁荣银行股份有限公司是一家银行控股公司，总部位于德克萨斯州休斯顿，业务覆盖德克萨斯州与俄克拉荷马州中部。截至2019年12月末，公司共运营285家分支网点，其中休斯顿地区（含伍德兰兹）65家，南德克萨斯（含科珀斯克里斯蒂、维多利亚）30家，达拉斯-沃斯堡大都会区75家，布局覆盖德克萨斯州各主要区域。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
EQBK vs PBYI — 直观对比
营收规模更大
PBYI
是对方的1.2倍
$63.5M
营收增速更快
EQBK
高出0.6%
27.7%
自由现金流更多
EQBK
多$23.7M
$14.4M
两年增速更快
PBYI
近两年复合增速
6.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $63.5M | $75.5M |
| 净利润 | $22.1M | — |
| 毛利率 | — | 69.3% |
| 营业利润率 | 41.7% | 22.7% |
| 净利率 | 34.8% | — |
| 营收同比 | 28.4% | 27.7% |
| 净利润同比 | 30.0% | — |
| 每股收益（稀释后） | $1.07 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收EQBKPBYI
| Q4 25 | $63.5M | $75.5M | ||
| Q3 25 | $18.0M | $54.5M | ||
| Q2 25 | $58.4M | $52.4M | ||
| Q1 25 | $60.6M | $46.0M | ||
| Q4 24 | $58.3M | $59.1M | ||
| Q3 24 | $55.3M | $80.5M | ||
| Q2 24 | $55.4M | $47.1M | ||
| Q1 24 | $55.9M | $43.8M |
净利润EQBKPBYI
| Q4 25 | $22.1M | — | ||
| Q3 25 | $-29.7M | $8.8M | ||
| Q2 25 | $15.3M | $5.9M | ||
| Q1 25 | $15.0M | $3.0M | ||
| Q4 24 | $17.0M | — | ||
| Q3 24 | $19.9M | $20.3M | ||
| Q2 24 | $11.7M | $-4.5M | ||
| Q1 24 | $14.1M | $-4.8M |
毛利率EQBKPBYI
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% | ||
| Q1 24 | — | 75.5% |
营业利润率EQBKPBYI
| Q4 25 | 41.7% | 22.7% | ||
| Q3 25 | -207.2% | 17.6% | ||
| Q2 25 | 31.5% | 12.7% | ||
| Q1 25 | 31.1% | 8.7% | ||
| Q4 24 | 35.0% | 22.6% | ||
| Q3 24 | 43.1% | 27.4% | ||
| Q2 24 | 29.4% | -4.6% | ||
| Q1 24 | 31.8% | -5.3% |
净利率EQBKPBYI
| Q4 25 | 34.8% | — | ||
| Q3 25 | -164.7% | 16.2% | ||
| Q2 25 | 26.1% | 11.2% | ||
| Q1 25 | 24.8% | 6.5% | ||
| Q4 24 | 29.1% | — | ||
| Q3 24 | 35.9% | 25.2% | ||
| Q2 24 | 21.1% | -9.6% | ||
| Q1 24 | 25.2% | -11.0% |
每股收益（稀释后）EQBKPBYI
| Q4 25 | $1.07 | $0.26 | ||
| Q3 25 | $-1.55 | $0.17 | ||
| Q2 25 | $0.86 | $0.12 | ||
| Q1 25 | $0.85 | $0.06 | ||
| Q4 24 | $1.06 | $0.40 | ||
| Q3 24 | $1.28 | $0.41 | ||
| Q2 24 | $0.76 | $-0.09 | ||
| Q1 24 | $0.90 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $97.5M |
| 总债务越低越好 | $443.2M | $22.7M |
| 股东权益账面价值 | $732.1M | $130.3M |
| 总资产 | $6.4B | $216.3M |
| 负债/权益比越低杠杆越低 | 0.61× | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资EQBKPBYI
| Q4 25 | — | $97.5M | ||
| Q3 25 | — | $94.4M | ||
| Q2 25 | — | $96.0M | ||
| Q1 25 | — | $93.2M | ||
| Q4 24 | — | $101.0M | ||
| Q3 24 | — | $96.7M | ||
| Q2 24 | — | $96.8M | ||
| Q1 24 | — | $107.2M |
总债务EQBKPBYI
| Q4 25 | $443.2M | $22.7M | ||
| Q3 25 | $486.9M | $34.0M | ||
| Q2 25 | $448.4M | $45.3M | ||
| Q1 25 | $376.9M | $56.7M | ||
| Q4 24 | $312.8M | $68.0M | ||
| Q3 24 | $437.5M | $79.3M | ||
| Q2 24 | $391.7M | $90.7M | ||
| Q1 24 | $367.1M | $102.0M |
股东权益EQBKPBYI
| Q4 25 | $732.1M | $130.3M | ||
| Q3 25 | $711.9M | $115.3M | ||
| Q2 25 | $635.6M | $104.7M | ||
| Q1 25 | $617.3M | $97.1M | ||
| Q4 24 | $592.9M | $92.1M | ||
| Q3 24 | $504.0M | $71.1M | ||
| Q2 24 | $461.4M | $48.5M | ||
| Q1 24 | $456.8M | $51.0M |
总资产EQBKPBYI
| Q4 25 | $6.4B | $216.3M | ||
| Q3 25 | $6.4B | $202.9M | ||
| Q2 25 | $5.4B | $194.9M | ||
| Q1 25 | $5.4B | $196.2M | ||
| Q4 24 | $5.3B | $213.3M | ||
| Q3 24 | $5.4B | $220.7M | ||
| Q2 24 | $5.2B | $205.0M | ||
| Q1 24 | $5.2B | $214.1M |
负债/权益比EQBKPBYI
| Q4 25 | 0.61× | 0.17× | ||
| Q3 25 | 0.68× | 0.30× | ||
| Q2 25 | 0.71× | 0.43× | ||
| Q1 25 | 0.61× | 0.58× | ||
| Q4 24 | 0.53× | 0.74× | ||
| Q3 24 | 0.87× | 1.12× | ||
| Q2 24 | 0.85× | 1.87× | ||
| Q1 24 | 0.80× | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $51.4M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | $38.1M | $14.4M |
| 自由现金流率自由现金流/营收 | 60.0% | 19.1% |
| 资本支出强度资本支出/营收 | 20.9% | 0.0% |
| 现金转化率经营现金流/净利润 | 2.33× | — |
| 过去12个月自由现金流最近4个季度 | $88.8M | $41.7M |
8季度趋势，按日历期对齐
经营现金流EQBKPBYI
| Q4 25 | $51.4M | $14.4M | ||
| Q3 25 | $8.5M | $9.7M | ||
| Q2 25 | $28.3M | $14.1M | ||
| Q1 25 | $21.7M | $3.6M | ||
| Q4 24 | $73.8M | $15.6M | ||
| Q3 24 | $23.5M | $11.0M | ||
| Q2 24 | $16.0M | $1.0M | ||
| Q1 24 | $12.6M | $11.2M |
自由现金流EQBKPBYI
| Q4 25 | $38.1M | $14.4M | ||
| Q3 25 | $4.5M | $9.7M | ||
| Q2 25 | $26.0M | $14.1M | ||
| Q1 25 | $20.2M | $3.6M | ||
| Q4 24 | $65.4M | $15.6M | ||
| Q3 24 | $19.7M | $11.0M | ||
| Q2 24 | $15.2M | $1.0M | ||
| Q1 24 | $10.6M | — |
自由现金流率EQBKPBYI
| Q4 25 | 60.0% | 19.1% | ||
| Q3 25 | 24.7% | 17.7% | ||
| Q2 25 | 44.5% | 26.8% | ||
| Q1 25 | 33.3% | 7.7% | ||
| Q4 24 | 112.1% | 26.4% | ||
| Q3 24 | 35.6% | 13.7% | ||
| Q2 24 | 27.4% | 2.1% | ||
| Q1 24 | 19.0% | — |
资本支出强度EQBKPBYI
| Q4 25 | 20.9% | 0.0% | ||
| Q3 25 | 22.3% | 0.0% | ||
| Q2 25 | 3.9% | 0.0% | ||
| Q1 25 | 2.4% | 0.1% | ||
| Q4 24 | 14.6% | 0.0% | ||
| Q3 24 | 6.8% | 0.0% | ||
| Q2 24 | 1.5% | 0.0% | ||
| Q1 24 | 3.6% | 0.0% |
现金转化率EQBKPBYI
| Q4 25 | 2.33× | — | ||
| Q3 25 | — | 1.10× | ||
| Q2 25 | 1.85× | 2.41× | ||
| Q1 25 | 1.44× | 1.21× | ||
| Q4 24 | 4.35× | — | ||
| Q3 24 | 1.18× | 0.54× | ||
| Q2 24 | 1.37× | — | ||
| Q1 24 | 0.90× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
